PartnerRe Asset Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-43,137
Closed -$1.21M 303
2016
Q1
$1.21M Sell
43,137
-738
-2% -$21.1K 0.62% 22
2015
Q4
$1.34M Sell
43,875
-73,769
-63% -$2.32M 0.69% 20
2015
Q3
$3.51M Buy
117,644
+411
+0.4% +$13.2K 0.6% 27
2015
Q2
$3.73M Sell
117,233
-19,632
-14% -$640K 0.7% 24
2015
Q1
$4.52M Sell
136,865
-4,566
-3% -$145K 0.75% 19
2014
Q4
$4.18M Buy
141,431
+19,112
+16% +$548K 0.68% 24
2014
Q3
$3.43M Sell
122,319
-20,635
-14% -$579K 0.67% 28
2014
Q2
$4.03M Sell
142,954
-19,632
-12% -$560K 0.71% 27
2014
Q1
$4.96M Sell
162,586
-1,852
-1% -$55.2K 0.83% 26
2013
Q4
$4.78M Sell
164,438
-13,404
-8% -$390K 0.82% 27
2013
Q3
$4.85M Sell
177,842
-25,107
-12% -$683K 0.82% 29
2013
Q2
$5.39M Buy
+202,949
New +$5.61M 0.87% 29

Other funds holding PFE

PartnerRe Asset Management's PFE Position: Q2 2016 in Review

PartnerRe Asset Management sold out of Pfizer (PFE) in Q2 2016, closing a stake of 43,137 shares — an estimated $1.21M sold.

PartnerRe Asset Management first reported a position in PFE in Q2 2013 and held it in 12 quarters. The position peaked at $5.39M in Q2 2013. 1,991 funds tracked by Wall St. Rank hold PFE as of Q2 2016.

  • PartnerRe Asset Management reported no remaining Pfizer position as of Q2 2016 after selling out during the quarter.
  • PartnerRe Asset Management sold 43,137 Pfizer shares in Q2 2016, an estimated $1.21M.
  • PartnerRe Asset Management first reported a position in Pfizer in Q2 2013 and held it in 12 quarters.
  • PartnerRe Asset Management's Pfizer position peaked at $5.39M in Q2 2013.
  • 1,991 funds tracked by Wall St. Rank held Pfizer as of Q2 2016.

Based on PartnerRe Asset Management's 13F filing for Q2 2016, filed 14 Jul 2016.